View Older Stories View More Recent Stories

May 24, 2024 04:30PM Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
May 13, 2024 05:46AM Recursion Pharmaceuticals (RXRX) Completes NVIDIA-Powered BioHive-2
May 13, 2024 05:00AM Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
May 9, 2024 04:01PM Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
May 2, 2024 08:00AM Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 1, 2024 08:01AM Recursion to Participate in Upcoming Investor Conferences
Apr 16, 2024 08:10AM Recursion Pharmaceuticals (RXRX) Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer
Apr 16, 2024 08:00AM Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Apr 16, 2024 08:00AM Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Apr 2, 2024 08:00AM Recursion to Participate in Upcoming Investor Conference
Mar 26, 2024 08:00AM Recursion Publishes Annual Environmental, Social and Governance Report
Mar 11, 2024 04:00AM Recursion Announces Plans to Open New Office in London
Mar 1, 2024 07:59AM Recursion to Participate in Upcoming Investor Conferences
Feb 27, 2024 04:05PM Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Feb 20, 2024 07:59AM Recursion to Host Public L(earnings) Call on February 27
Jan 8, 2024 10:59AM Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Jan 4, 2024 07:59AM Recursion Pharmaceuticals (RXRX) Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Jan 4, 2024 07:59AM Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Jan 3, 2024 08:00AM Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
Dec 20, 2023 07:59AM Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
Nov 9, 2023 01:49PM Recursion (RXRX) and Bayer Focus Research Collaboration on Oncology
Nov 9, 2023 01:48PM Bayer and Recursion focus research collaboration on Oncology
Nov 9, 2023 09:43AM Bayer and Recursion (RXRX) Focus Research Collaboration on Oncology
Nov 9, 2023 09:41AM Bayer and Recursion Focus Research Collaboration on Oncology
Nov 9, 2023 08:01AM Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
Nov 9, 2023 07:58AM Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
Nov 2, 2023 08:05AM Recursion to Participate in Upcoming Investor Conference
Sep 5, 2023 04:30PM Recursion to Participate in Upcoming Investor Conferences
Sep 5, 2023 07:59AM Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
Aug 8, 2023 08:00AM Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
Aug 8, 2023 07:58AM Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
Aug 1, 2023 08:30AM Recursion to Participate in Upcoming Investor Conference
Jul 26, 2023 07:03PM Recursion Pharmaceuticals (RXRX) Launches Valence Labs
Jul 26, 2023 06:58PM Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
Jul 12, 2023 08:32AM Recursion Pharmaceuticals (RXRX) Announces Collaboration and $50M Investment from NVIDIA (NVDA)
Jul 12, 2023 08:30AM Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Jun 26, 2023 11:48AM Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
Jun 13, 2023 08:00AM Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
Jun 1, 2023 08:30AM Recursion to Participate in Upcoming Investor Conferences
May 25, 2023 04:00PM Altitude Lab Relocates to Gateway’s BioHive Hub
May 16, 2023 08:30AM Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
May 8, 2023 08:14AM Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
May 8, 2023 07:59AM Recursion Pharmaceuticals (RXRX) to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
May 8, 2023 07:59AM Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
May 2, 2023 08:30AM Recursion to Participate in Upcoming Investor Conferences
May 2, 2023 08:30AM Recursion to Participate in Upcoming Investor Conferences
Apr 3, 2023 08:30AM Recursion to Participate in Upcoming Investor Conference
Apr 3, 2023 08:30AM Recursion to Participate in Upcoming Investor Conference
Mar 28, 2023 04:14PM Recursion Publishes Second Annual Environmental, Social and Governance Report
Mar 28, 2023 04:14PM Recursion Publishes Second Annual Environmental, Social and Governance Report
View More Recent Stories View Older Stories